Read the story here. Advertise at Before It's News here.
Profile image
By ProactiveInvestors (Reporter)
Contributor profile | More stories
Story Views
Last hour:
Last 24 hours:

Kazia Therapeutics appoints former Cellectar Biosciences chief medical officer John Friend as new CMO

% of readers think this story is Fact. Add your two cents.

Kazia Therapeutics Ltd (ASX:KZA, NASDAQ:KZIA) has appointed John Friend MD, the former chief medical officer (CMO) at Cellectar Biosciences (NASDAQ:CLRB), Inc as its new CMO. 

Dr Friend will be responsible for overseeing the development and commercialization of Kazia’s pipeline drug candidates, and collaborate with clinicians and scientists to advance the company’s research programs. 

He will be based in New Jersey in the US.

Timely appointment

Kazia chief executive officer James Garner said: “We are delighted to welcome John to the Kazia team.

“With paxalisib moving rapidly towards potential commercialization, and EVT801 now in the clinic, this appointment is very timely.

“John is a highly experienced oncology and haematology drug developer who brings to Kazia a wealth of expertise, as well as a passion for improving the lives of patients with cancer.”

Driving pipeline forward

Dr Friend added: “I look forward to working with Kazia colleagues to drive the company’s pipeline forward toward its full potential.

“Both paxalisib and EVT801 have enormous scope to address unmet needs in a number of different tumour types and I am pleased to be working with world-renowned cancer centers and their leading clinicians to develop these promising new therapies.

“I am delighted to join Kazia at such an exciting and pivotal time for the company.”

Career spanning over 25 years

Dr Friend gained his medical degree at Rutgers University (UMDNJ-Robert Wood Johnson) and also holds a BA in chemistry from Southern Methodist University.

In a career spanning more than 25 years, he has worked across a wide range of therapeutic areas in roles spanning early clinical research through to medical affairs.

He spent seven years with the US business unit of Helsinn Therapeutics, a leading European specialty pharmaceutical company before leaving the company as senior vice president of Medical and Scientific Affairs.

Story by ProactiveInvestors


Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world.

Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.

"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.

Please Help Support BeforeitsNews by trying our Natural Health Products below!

Order by Phone at 888-809-8385 or online at M - F 9am to 5pm EST

Order by Phone at 888-388-7003 or online at M - F 9am to 5pm EST

Order by Phone at 888-388-7003 or online at M - F 9am to 5pm EST

Humic & Fulvic Trace Minerals Complex - Nature's most important supplement! Vivid Dreams again!

HNEX HydroNano EXtracellular Water - Improve immune system health and reduce inflammation

Ultimate Clinical Potency Curcumin - Natural pain relief, reduce inflammation and so much more.

MitoCopper - Bioavailable Copper destroys pathogens and gives you more energy. (See Blood Video)
Oxy Powder - Natural Colon Cleanser!  Cleans out toxic buildup with oxygen! 
Nascent Iodine - Promotes detoxification, mental focus and thyroid health.
Smart Meter Cover -  Reduces Smart Meter radiation by 96%!  (See Video)

Report abuse


Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

Load more ...




Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.